Abstract
Identification of transcription factors that directly convert pluripotent stem cells (PSCs) into endothelial and blood cells and advances in the chemical modifications of messenger RNA (mRNA) offer alternative nucleic acid-based transgene-free approach for scalable production of these cells for drug screening and therapeutic purposes. Here we evaluated the effect of 5′ and 3′ RNA untranslated regions (UTRs) on translational efficiency of chemically-modified synthetic mRNA (modRNA) in human PSCs and showed that an addition of 5′UTR indeed enhanced protein expression. With the optimized modRNAs expressing ETV2 or ETV2 and GATA2, we are able to produce VE-cadherin+ endothelial cells and CD34+CD43+ hematopoietic progenitors, respectively, from human PSCs as well as non-human primate (NHP) PSCs. Overall, our findings provide valuable information on the design of in vitro transcription templates being used in PSCs and its broad applicability for basic research, disease modeling, and regenerative medicine.
Similar content being viewed by others
References
Szabo, E., Rampalli, S., Risueno, R. M., et al. (2010). Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 468(7323), 521–526.
Vierbuchen, T., Ostermeier, A., Pang, Z. P., et al. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463(7284), 1035–1041.
Lis, R., Karrasch, C. C., Poulos, M. G., et al. (2017). Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature, 545(7655), 439 – 445.
Elcheva, I., Brok-Volchanskaya, V., Kumar, A., et al. (2014). Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nature Communications, 5, 4372.
Oh, S., & Kessler, J. A. (2017). Design, assembly, production, and transfection of synthetic modified mRNA. Methods.
Holtkamp, S., Kreiter, S., Selmi, A., et al. (2006). Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood, 108(13), 4009–4017.
Kranz, L. M., Diken, M., Haas, H., et al. (2016). Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature, 534(7607), 396–401.
Warren, L., Manos, P. D., Ahfeldt, T., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7(5), 618 – 630.
Kormann, M. S., Hasenpusch, G., Aneja, M. K., et al. (2011). Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nature Biotechnology, 29(2), 154–157.
Huppert, J. L., & Balasubramanian, S. (2005). Prevalence of quadruplexes in the human genome. Nucleic Acids Research, 33(9), 2908–2916.
Kumari, S., Bugaut, A., Huppert, J. L., et al. (2007). An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translation. Nature Chemical Biology, 3(4), 218 – 21.
D’Souza, S. S., Maufort, J., Kumar, A., et al. (2016). GSK3beta inhibition promotes efficient myeloid and lymphoid hematopoiesis from non-human primate-induced pluripotent stem cells. Stem Cell Reports, 6(2), 243 – 56.
Chen, G., Gulbranson, D. R., Hou, Z., et al. (2011). Chemically defined conditions for human iPSC derivation and culture. Nature Methods, 8(5), 424–429.
Uenishi, G., Theisen, D., Lee, J. H., et al. (2014). Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports, 3(6), 1073–1084.
Gebauer, F., & Hentze, M. W. (2004). Molecular mechanisms of translational control. Nature Reviews Molecular Cell Biology, 5(10), 827 – 835.
Kozak, M. (1994). Features in the 5′ non-coding sequences of rabbit α and β-globin mRNAs that affect translational efficiency. Journal of Molecular Biology, 235(1), 95–110.
Jiang, H., & Lucy, M. C. (2001). Variants of the 5′-untranslated region of the bovine growth hormone receptor mRNA: isolation, expression and effects on translational efficiency. Gene, 265(1–2), 45–53.
Conne, B., Stutz, A., & Vassalli, J. D. (2000). The 3′ untranslated region of messenger RNA: A molecular ‘hotspot’ for pathology? Nature Medicine, 6(6), 637 – 41.
Leonhardt, C., Schwake, G., Stogbauer, T. R., et al. (2014). Single-cell mRNA transfection studies: delivery, kinetics and statistics by numbers. Nanomedicine, 10(4), 679 – 88.
Corish, P., & Tyler-Smith, C. (1999). Attenuation of green fluorescent protein half-life in mammalian cells. Protein Engineering, 12(12), 1035–1040.
Morita, R., Suzuki, M., Kasahara, H., et al. (2015). ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 112(1), 160–165.
Yamamizu, K., Matsunaga, T., Katayama, S., et al. (2012). PKA/CREB signaling triggers initiation of endothelial and hematopoietic cell differentiation via Etv2 induction. Stem Cells, 30(4), 687 – 696.
Sgourou, A., Routledge, S., Antoniou, M., et al. (2004). Thalassaemia mutations within the 5′UTR of the human beta-globin gene disrupt transcription. British Journal of Haematology, 124(6), 828 – 35.
Levenberg, S., Zoldan, J., Basevitch, Y., et al. (2007). Endothelial potential of human embryonic stem cells. Blood, 110(3), 806 – 14.
Ng, E. S., Azzola, L., Bruveris, F. F., et al. (2016). Differentiation of human embryonic stem cells to HOXA + hemogenic vasculature that resembles the aorta-gonad-mesonephros. Nature Biotechnology, 34(11), 1168–1179.
Vodyanik, M. A., Bork, J. A., Thomson, J. A., et al. (2005). Human embryonic stem cell-derived CD34 + cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood, 105(2), 617 – 626.
Wang, Z. Z., Au, P., Chen, T., et al. (2007). Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nature Biotechnology, 25(3), 317–318.
Patsch, C., Challet-Meylan, L., Thoma, E. C., et al. (2015). Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nature Cell Biology, 17(8), 994–1003.
Orlova, V. V., Drabsch, Y., Freund, C., et al. (2014). Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(1), 177 – 186.
Budde, M. L., Wiseman, R. W., Karl, J. A., et al. (2010). Characterization of Mauritian cynomolgus macaque major histocompatibility complex class I haplotypes by high-resolution pyrosequencing. Immunogenetics, 62(11–12), 773 – 780.
Wiseman, R. W., Karl, J. A., Bohn, P. S., et al. (2013). Haplessly hoping: macaque major histocompatibility complex made easy. ILAR Journal, 54(2), 196–210.
Wiseman, R. W., Wojcechowskyj, J. A., Greene, J. M., et al. (2007). Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. Journal of Virology, 81(1), 349 – 361.
Acknowledgements
We thank the Cell Processing and Manipulation Core in the Translational Cores, and Physicians and Nurses at University of Wisconsin Carbone Cancer Center and Cincinnati Children’s Hospital Medical Center for obtaining and processing bone marrow samples and Translational Research Trials Office for providing the regulatory and administrative support for this endeavor. This work was supported by funds from the National Institute of Health (1R01HL132891, 4R01HL116221, and P51OD011106).
Author information
Authors and Affiliations
Contributions
K.S. designed and conducted experiments and wrote the manuscript, L.T. conducted eGFP experiments, V.B.V. conducted hematopoietic developmental assays, S.S.D. conducted NHP-related experiments, A.K. conducted endothelial developmental assays, I.S. conceptualized and supervised all aspects of the studies and wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
Authors declare no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
eGFP expression in non-human primate iPSC
. Bar graph showing eGFP mean fluorescence intensity (MFI) from MnCy0669 iPSC at 24 h after transfection with different eGFP modRNAs. Results are represented as mean ± SD from 3 independent experiments. * indicates significance (TIF 140 KB)
Quantitative PCR analyses of endothelial and hematopoietic genes
. Expression of indicated genes were calculated relative to GAPDH using ΔΔCt method. Results are represented as mean ± SD (n = 3). EC = endothelial cells, 43 + = CD43+ cells, CB = cord blood, BM = bone marrow, MNC = mononuclear cells, HUVEC = human umbilical vein endothelial cells (TIF 2474 KB)
Generation of hematopoietic cells from primate iPSC. A)
Representative picture of day 7 hematopoietic cells (arrow) formation from MnCy0669 iPSC. Flow cytometric histogram showing percentage of CD34 in the floating cell fraction. B) Representative picture of hematopoietic colonies and Wright-stained cytospin from MnCy0669 iPSC. Scale bar = 200 μm (TIF 633 KB)
Rights and permissions
About this article
Cite this article
Suknuntha, K., Tao, L., Brok-Volchanskaya, V. et al. Optimization of Synthetic mRNA for Highly Efficient Translation and its Application in the Generation of Endothelial and Hematopoietic Cells from Human and Primate Pluripotent Stem Cells. Stem Cell Rev and Rep 14, 525–534 (2018). https://doi.org/10.1007/s12015-018-9805-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-018-9805-1